Federated Hermes, Inc. Scynexis Inc Transaction History
Federated Hermes, Inc.
- $52.5 Billion
- Q3 2025
A detailed history of Federated Hermes, Inc. transactions in Scynexis Inc stock. As of the latest transaction made, Federated Hermes, Inc. holds 1,583,348 shares of SCYX stock, worth $934,175. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,583,348
Previous 2,895,000
45.31%
Holding current value
$934,175
Previous $1.94 Million
32.23%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding SCYX
# of Institutions
47Shares Held
12.5MCall Options Held
0Put Options Held
0-
Avidity Partners Management LP Dallas, TX3.35MShares$1.98 Million1.43% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY2.24MShares$1.32 Million0.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.76MShares$1.04 Million0.0% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC556KShares$327,7770.7% of portfolio
-
Black Rock Inc. New York, NY424KShares$250,0050.0% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $19.3M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...